Is the risk of ischemic heart disease in women after radiotherapy for breast cancer nowadays still (linearly) associated with the mean heart dose?

Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557–65.

https://doi.org/10.1016/S1470-2045(05)70251-5 DOI: https://doi.org/10.1016/S1470-2045(05)70251-5

Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.

https://doi.org/10.1056/NEJMoa1209825 DOI: https://doi.org/10.1056/NEJMoa1209825

Jacobse JN, Duane FK, Boekel NB, et al. Radiation dose-response for risk of myocardial infarction in breast cancer survivors. Int J Radiat Oncol Biol Phys. 2019;103(3):595–604.

https://doi.org/10.1016/j.ijrobp.2018.10.025 DOI: https://doi.org/10.1016/j.ijrobp.2018.10.025

van den Bogaard VAB, Ta BDP, van der Schaaf A, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35(11):1171–8.

https://doi.org/10.1200/JCO.2016.69.8480 DOI: https://doi.org/10.1200/JCO.2016.69.8480

Lorenzen EL, Rehammar JC, Jensen MB, Ewertz M, Brink C. Radiation-induced risk of ischemic heart disease following breast cancer radiotherapy in Denmark, 1977–2005. Radiother Oncol. 2020;152:103–10.

https://doi.org/10.1016/j.radonc.2020.08.007 DOI: https://doi.org/10.1016/j.radonc.2020.08.007

Mutter RW, Choi I, Jimenez RB, et al. Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative group breast cancer subcommittee. Int J Radiat Oncol Biol Phys. 2021;111(2):337–59.

https://doi.org/10.1016/j.ijrobp.2021.05.110 DOI: https://doi.org/10.1016/j.ijrobp.2021.05.110

National Guideline Alliance (UK). Evidence reviews for breast radiotherapy: early and locally advanced breast cancer: diagnosis and management: evidence review H [Internet]. London: National Institute for Health and Care Excellence (NICE); 2018 Jul. (NICE Guideline, No. 101.) [Cited date: 30-11-2023] Available from: https://www.ncbi.nlm.nih.gov/books/NBK576827/

Stick LB, Lorenzen EL, Yates ES, et al. Selection criteria for early breast cancer patients in the DBCG-proton trial – the randomised phase III trial strategy. Clin Transl Radiat Oncol. 2021;27:126–31.

https://doi.org/10.1016/j.ctro.2021.01.012 DOI: https://doi.org/10.1016/j.ctro.2021.01.012

Baaken D, Merzenich H, Schmidt M, et al. A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in Germany. Breast. 2022;65:1–7.

https://doi.org/10.1016/j.breast.2022.05.007 DOI: https://doi.org/10.1016/j.breast.2022.05.007

Holm Milo ML, Slot Møller D, Bisballe Nyeng T, et al. Radiation dose to heart and cardiac substructures and risk of coronary artery disease in early breast cancer patients: a DBCG study based on modern radiation therapy techniques. Radiother Oncol. 2023;180:109453.

https://doi.org/10.1016/j.radonc.2022.109453 DOI: https://doi.org/10.1016/j.radonc.2022.109453

Duane FK, Boekel NB, Jacobse JN, et al. Exposure of the heart and cardiac valves in women irradiated for breast cancer 1970–2009. Clin Transl Radiat Oncol. 2022;36:132–9.

https://doi.org/10.1016/j.ctro.2022.07.004 DOI: https://doi.org/10.1016/j.ctro.2022.07.004

Taylor CW, Wang Z, Macaulay E, Jagsi R, Duane F, Darby SC. Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013. Rev Int J Radiat Oncol Biol Phys. 2015;93(4):845–53.

https://doi.org/10.1016/j.ijrobp.2015.07.2292 DOI: https://doi.org/10.1016/j.ijrobp.2015.07.2292

WHO Mortality Database. Notes: Data are age-standardised to the 2013 European standard population [Internet]. Available from: [Cited date: 30-11-2023] http://apps.who.int/healthinfo/statistics/mortality/whodpms/

Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–37.

https://doi.org/10.1093/eurheartj/ehab484 DOI: https://doi.org/10.1093/eurheartj/ehab484

Kesteloot H, Sans S, Kromhout D. Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J. 2006;27:107–13.

https://doi.org/10.1093/eurheartj/ehi511 DOI: https://doi.org/10.1093/eurheartj/ehi511

Hooning MJ, Botma A, Aleman BM, et al. Long-term risk of cardiovascular disease in 10-years survivors of breast cancer. J Natl Cancer Inst. 2007;99:365–75.

https://doi.org/10.1093/jnci/djk064 DOI: https://doi.org/10.1093/jnci/djk064

Taylor C, Correa C, Duane FK, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol 2017;35(15):1641–9.

https://doi.org/10.1200/JCO.2016.72.0722 DOI: https://doi.org/10.1200/JCO.2016.72.0722

Mehta LS, Watson KE, Barac A, et al. Cardio-vascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–66.

https://doi.org/10.1161/CIR.0000000000000556 DOI: https://doi.org/10.1161/CIR.0000000000000556

Bogers SLC, Petoukhova AL, Penninkhof JJ, et al. Target volume coverage and organ at risk doses for left-sided whole breast irradiation with or without internal mammary chain irradiation: a comparison between 3 techniques representing the past and the present. Clin Oncol (R Coll Radiol). 2022;34(8):537–44.

https://doi.org/10.1016/j.clon.2022.04.004 DOI: https://doi.org/10.1016/j.clon.2022.04.004

Ranger A, Dunlop A, Hutchinson K, et al. A Dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain. Clin Oncol (R Coll Radiol). 2018;30(6):346–53.

https://doi.org/10.1016/j.clon.2018.01.017 DOI: https://doi.org/10.1016/j.clon.2018.01.017

Overgaard M, Nielsen HM, Tramm T, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol. 2022;170:4–13.

https://doi.org/10.1016/j.radonc.2022.03.008 DOI: https://doi.org/10.1016/j.radonc.2022.03.008

EBCTCG. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) Lancet. 2023;402(10416):1991–2003.

https://doi.org/10.1016/S0140-6736(23)01082-6 DOI: https://doi.org/10.1016/S0140-6736(23)01082-6

Poortmans PM, Struikmans H, de Brouwer P, et al. Side effects 15-years after lymph node irradiation in breast cancer: randomized EORTC Trial 22922/10925. J Natl Cancer Inst. 2021;113(10):1360–8.

https://doi.org/10.1093/jnci/djab113 DOI: https://doi.org/10.1093/jnci/djab113

Mast ME, van Kempen-Harteveld L, et al. Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further? Radiother Oncol. 2013;108(2):248–53.

https://doi.org/10.1016/j.radonc.2013.07.017 DOI: https://doi.org/10.1016/j.radonc.2013.07.017

Bentzen SM, Agrawal RK, Aird EG, et al. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371(9618):1098–107.

https://doi.org/10.1016/S0140-6736(08)60348-7 DOI: https://doi.org/10.1016/S0140-6736(08)60348-7

Brunt AM, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395(10237):1613–26.

https://doi.org/10.1016/S0140-6736(20)30932-6 DOI: https://doi.org/10.1016/S0140-6736(20)30932-6

Taylor CW, Povall JM, McGale P, et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys. 2008;72:501–7.

https://doi.org/10.1016/j.ijrobp.2007.12.058 DOI: https://doi.org/10.1016/j.ijrobp.2007.12.058